Shop for Health Tests
Explore Women's Health
Annual Wellness Guidelines
More

Diseases & Therapeutic Areas

Cancer & Oncology
Neurology
Rheumatology
More

Treatment Modalities & Methods

Cell & Gene Therapies
Precision Medicine
Radiopharmaceuticals
Vaccines
More

Scientific Lab Disciplines

Genetics
Digital Pathology & AI
Toxicology
More

Labs

Diagnostic Reference & Specialty Labs
Nonclinical Labs
Central Labs

Industries

Healthcare
Pharma
Medtech
Crop & Agricultural
Chemical & Environmental
Novel Food Safety Testing

Education, events & experts

Genetics
Genetics
Providers
Providers
Providers
Testing
Genetic Counseling
Individuals & Patients
Individuals & Patients
Individuals & Patients
Testing
Billing
About Genetic Testing

Lab Appointments

Diseases & Conditions

FAQs

Genetic Counseling
Biopharma
Biopharma
Commercial Partnerships
Commercial Partnerships
Scientific Expertise
Scientific Expertise
Scientific Expertise

Blog
Contact
Contact

Genetics

Scientific Expertise

Articles - 6 May 2025

The Pulse of Genetic Counselors

News & Updates

Articles - 17 October 2025

Skeletal Dysplasia

Articles - 17 October 2025

From Data to Discovery: Advancing Skeletal Dysplasia Research

Articles - 16 October 2025

Colorectal cancer and the power of genetic testing in routine oncology practice

Articles - 10 October 2025

A baby girl’s legacy lives on: What advances in genetic testing for rare diseases can mean for families everywhere

Search our knowledge library

Filter By

Recent

Posters, presentations & publications

Presentation — 1 June Jun 2024

Oncology

Real World Cancer Care Utilization among Breast Cancer Patients with Germline Variants of Uncertain Significance

Read more Read More about Real World Cancer Care Utilization among Breast Cancer Patients with Germline Variants of Uncertain Significance

Posters — 1 June Jun 2024

Oncology

Real World Cancer Care Utilization among Breast Cancer Patients with Germline Variants of Uncertain Significance

Read more Read More about Real World Cancer Care Utilization among Breast Cancer Patients with Germline Variants of Uncertain Significance

Presentation — 31 May May 2024

Oncology

Tracking Uncertainty in Germline Genetic Testing for Hereditary Cancer Syndromes: Sources, Attributes, and Resolution of Variants of Uncertain Significance in Over 1 Million Individuals

Read more Read More about Tracking Uncertainty in Germline Genetic Testing for Hereditary Cancer Syndromes: Sources, Attributes, and Resolution of Variants of Uncertain Significance in Over 1 Million Individuals

Posters — 31 May May 2024

Oncology

Tracking Uncertainty in Germline Genetic Testing for Hereditary Cancer Syndromes: Sources, Attributes, and Resolution of Variants of Uncertain Significance in Over 1 Million Individuals

Presentation — 3 May May 2024

Oncology

Germline Genetic Testing in a Broad Cohort of Renal Cell Carcinoma Patients

Read more Read More about Germline Genetic Testing in a Broad Cohort of Renal Cell Carcinoma Patients

Presentation — 1 May May 2024

Oncology

Patterns and presentations of mosaic variation in monogenic acquired errors of immunity

Read more Read More about Patterns and presentations of mosaic variation in monogenic acquired errors of immunity

Presentation — 12 March Mar 2024

Oncology

The Landscape of Variant Reclassification: Learnings from over 2 Million Classified Variants in over 3.6 Million Individuals

Read more Read More about The Landscape of Variant Reclassification: Learnings from over 2 Million Classified Variants in over 3.6 Million Individuals

Posters — 12 March Mar 2024

Oncology

Novel high-throughput functional models for MLH1, MSH2, PMS2 and MSH6 have high accuracy for clinical variant classification

Read more Read More about Novel high-throughput functional models for MLH1, MSH2, PMS2 and MSH6 have high accuracy for clinical variant classification

Presentation — 1 November Nov 2023

Oncology

The estimated healthcare spend to identify 1 hereditary cancer syndrome patient with a deep intronic pathogenic variant by rna sequencing is nearly 500x more costly than identifying 1 patient with multi-gene panel dna testing

Read more Read More about The estimated healthcare spend to identify 1 hereditary cancer syndrome patient with a deep intronic pathogenic variant by rna sequencing is nearly 500x more costly than identifying 1 patient with multi-gene panel dna testing

Presentation — 1 November Nov 2023

Oncology

Eight years and 1.8 million variants later: a historical exploration of variant reclassification rates to evaluate the acmg/amp variant classification framework and understand the major contributors to resolving variants of uncertain significance

Read more Read More about Eight years and 1.8 million variants later: a historical exploration of variant reclassification rates to evaluate the acmg/amp variant classification framework and understand the major contributors to resolving variants of uncertain significance

Presentation — 1 November Nov 2023

Oncology

Harnessing genotype and phenotype data from 3 million patients referred for clinical genetic testing for scalable, bayesian variant interpretation

Read more Read More about Harnessing genotype and phenotype data from 3 million patients referred for clinical genetic testing for scalable, bayesian variant interpretation

Presentation — 26 October Oct 2023

Oncology

Machine learning models impact In reducing variants Of uncertain significance In individuals undergoing genetic testing for gastrointestinal cancers

Read more Read More about Machine learning models impact In reducing variants Of uncertain significance In individuals undergoing genetic testing for gastrointestinal cancers

Presentation — 26 October Oct 2023

Oncology

Germline pathogenic variant prevalence among Latin American and US Hispanic individuals with gastrointestinal cancer or polyps undergoing testing

Read more Read More about Germline pathogenic variant prevalence among Latin American and US Hispanic individuals with gastrointestinal cancer or polyps undergoing testing

Presentation — 27 September Sep 2023

Oncology

Modeling cellular evidence: Approaches for generating, validating and incorporating data from functional assays to improve clinical variant classification

Read more Read More about Modeling cellular evidence: Approaches for generating, validating and incorporating data from functional assays to improve clinical variant classification

Presentation — 31 August Aug 2023

Oncology

Cascade testing with comprehensive multigene panels for hereditary cancer identifies unexpected findings in relatives

Read more Read More about Cascade testing with comprehensive multigene panels for hereditary cancer identifies unexpected findings in relatives

Recorded

Videos & webinars

Webinars — 29 September Sep 2025

Oncology

Harnessing the power of laboratory data to optimize trial design, site identification and patient recruitment

Read more Read More about Harnessing the power of laboratory data to optimize trial design, site identification and patient recruitment

Webinars — 25 September Sep 2025

Oncology

Inside the future of genetics: How leaders are scaling precision medicine across care settings

Read more Read More about Inside the future of genetics: How leaders are scaling precision medicine across care settings

Webinars — 25 September Sep 2025

Oncology

Making Sense of MAVEs: How Machine Learning and Human Expertise are Improving Variant Classification and Clinical Actionability

Read more Read More about Making Sense of MAVEs: How Machine Learning and Human Expertise are Improving Variant Classification and Clinical Actionability

Webinars — 21 August Aug 2025

Oncology

The Importance of Human Expertise in AI-Informed Variant Interpretation Workflows

Read more Read More about The Importance of Human Expertise in AI-Informed Variant Interpretation Workflows

Webinars — 12 June Jun 2025

Oncology

The Importance of Human Expertise: Genetic Testing from Sample to Report

Read more Read More about The Importance of Human Expertise: Genetic Testing from Sample to Report

Webinars — 22 May May 2025

Oncology

From Uncertainty to Action: Harnessing Industry Leading Variant Classification to Optimize Healthcare Provider Engagement

Read more Read More about From Uncertainty to Action: Harnessing Industry Leading Variant Classification to Optimize Healthcare Provider Engagement

Videos — 10 October Oct 2024

Oncology

The evolution of Sherloc: Insights into the innovative and scalable approaches impacting variant classification

Read more Read More about The evolution of Sherloc: Insights into the innovative and scalable approaches impacting variant classification

Webinars — 7 October Oct 2024

Oncology

Navigating the nontraditional: A look into fertility challenges and novel referral indications

Read more Read More about Navigating the nontraditional: A look into fertility challenges and novel referral indications

Webinars — 21 June Jun 2024

Oncology

Carrier screening: Providing valuable insights for you and your patients

Read more Read More about Carrier screening: Providing valuable insights for you and your patients

Webinars — 28 May May 2024

Oncology

Reducing uncertainty in variant classification by leveraging the capabilities of evidence modeling

Read more Read More about Reducing uncertainty in variant classification by leveraging the capabilities of evidence modeling

Webinars — 15 May May 2024

Oncology

Overcoming key challenges in global cell and gene therapy trials with Labcorp

Read more Read More about Overcoming key challenges in global cell and gene therapy trials with Labcorp

Videos — 30 April Apr 2024

Oncology

From complexity to clarity: Making sense of mosaic variants and preliminary evidence genes

Read more Read More about From complexity to clarity: Making sense of mosaic variants and preliminary evidence genes

Webinars — 21 March Mar 2024

Oncology

Improving variant classifications in Lynch Syndrome genes through functional data generation and clinical data modeling

Read more Read More about Improving variant classifications in Lynch Syndrome genes through functional data generation and clinical data modeling

Webinars — 28 February Feb 2024

Oncology

The road to integrating genetic testing into the electronic health record: An epic interfacing journey

Read more Read More about The road to integrating genetic testing into the electronic health record: An epic interfacing journey

Webinars — 15 November Nov 2023

Oncology

Innovations in variant interpretation: Learning from over 8 years of variant reclassifications

Read more Read More about Innovations in variant interpretation: Learning from over 8 years of variant reclassifications

Webinars — 9 November Nov 2023

Oncology

Implementation of mainstreaming for hereditary breast cancer risk assessment and genetic testing

Read more Read More about Implementation of mainstreaming for hereditary breast cancer risk assessment and genetic testing

Webinars — 27 September Sep 2023

Oncology

Germline genetic testing in patients with prostate cancer: Bridging the gap between guidelines and clinical implementation

Read more Read More about Germline genetic testing in patients with prostate cancer: Bridging the gap between guidelines and clinical implementation

Webinars — 30 August Aug 2023

Oncology

Innovations in variant interpretation: Navigating the VUS landscape

Read more Read More about Innovations in variant interpretation: Navigating the VUS landscape

Webinars — 1 August Aug 2023

Oncology

Providing genetic insights: Diagnostic yield from molecular testing in arrhythmias, cardiomyopathies, and lipidemias

Read more Read More about Providing genetic insights: Diagnostic yield from molecular testing in arrhythmias, cardiomyopathies, and lipidemias

Webinars — 6 June Jun 2023

Oncology

Innovations in variant interpretation: An introduction to a Bayesian approach

Read more Read More about Innovations in variant interpretation: An introduction to a Bayesian approach

Videos — 23 May May 2023

Oncology

A new look at an old standard: What you may not know about how we understand CFTR and its clinical presentations today

Read more Read More about A new look at an old standard: What you may not know about how we understand CFTR and its clinical presentations today

Webinars — 26 April Apr 2023

Oncology

Innovations in variant interpretation: The role of cellular evidence modeling

Read more Read More about Innovations in variant interpretation: The role of cellular evidence modeling

Webinars — 30 March Mar 2023

Oncology

To test or not to test: Examining the pros and cons of universal germline genetic testing among patients with colorectal cancer

Read more Read More about To test or not to test: Examining the pros and cons of universal germline genetic testing among patients with colorectal cancer

Webinars — 22 February Feb 2023

Oncology

21st Century Cures Act & Empowering Patients with Data

Read more Read More about 21st Century Cures Act & Empowering Patients with Data

Webinars — 1 January Jan 2023

Oncology

Beyond the clinical diagnosis: The impact of genetic testing for cardiomyopathies and arrhythmias

Read more Read More about Beyond the clinical diagnosis: The impact of genetic testing for cardiomyopathies and arrhythmias

Videos — 1 January Jan 2023

Oncology

Genetic testing in epilepsy: Improving clinical outcomes through improved diagnostic yield and precision medicine

Read more Read More about Genetic testing in epilepsy: Improving clinical outcomes through improved diagnostic yield and precision medicine

Webinars — 9 November Nov 2022

Oncology

The benefits and limitations of artificial intelligence and machine learning in clinical genomics and variant interpretation

Read more Read More about The benefits and limitations of artificial intelligence and machine learning in clinical genomics and variant interpretation

Videos — 19 November Nov 2021

Oncology

Autologous CAR T Development Safety Assessment and Monitoring In Preclinical and Clinical Programs - with English Subtitles

Read more Read More about Autologous CAR T Development Safety Assessment and Monitoring In Preclinical and Clinical Programs - with English Subtitles

Videos — 2 November Nov 2021

Oncology

Digital Pathology Solutions for Drug Development and Diagnostics

Read more Read More about Digital Pathology Solutions for Drug Development and Diagnostics

Videos — 9 March Mar 2018

Oncology

Leveraging Key Biomarkers to Advance Immuno-Oncology Drug Development and Find the Right Trial Participants

Read more Read More about Leveraging Key Biomarkers to Advance Immuno-Oncology Drug Development and Find the Right Trial Participants

Videos — 25 October Oct 2016

Oncology

The Role of a CRO in Immuno-Oncology Studies - Introduction

Read more Read More about The Role of a CRO in Immuno-Oncology Studies - Introduction

Videos — 24 October Oct 2016

Oncology

The Role of a CRO in Immuno-Oncology Studies

Read more Read More about The Role of a CRO in Immuno-Oncology Studies

Videos — 23 October Oct 2016

Oncology

The Role of a CRO in Immuno-Oncology Studies - Biomarker Assays

Read more Read More about The Role of a CRO in Immuno-Oncology Studies - Biomarker Assays

Videos — 22 October Oct 2016

Oncology

The Role of a CRO in Immuno-Oncology Studies - Companion & Complementary Diagnostics

Read more Read More about The Role of a CRO in Immuno-Oncology Studies - Companion & Complementary Diagnostics

Videos — 21 October Oct 2016

Oncology

The Role of a CRO in Immuno-Oncology Studies - Genomics Biomarkers

Read more Read More about The Role of a CRO in Immuno-Oncology Studies - Genomics Biomarkers

Videos — 20 October Oct 2016

Oncology

The Role of a CRO in Immuno-Oncology Studies - Summary

Read more Read More about The Role of a CRO in Immuno-Oncology Studies - Summary

Videos — 10 October Oct 2016

Oncology

The Role of Biomarkers and Companion / Complementary Diagnostics in Immuno-Oncology Trials

Read more Read More about The Role of Biomarkers and Companion / Complementary Diagnostics in Immuno-Oncology Trials

Videos — 8 June Jun 2015

Oncology

Pragmatic Solutions for Immuno-Oncology Clinical Trial Programs

Read more Read More about Pragmatic Solutions for Immuno-Oncology Clinical Trial Programs

Featured

Scientific team members

Chevonne Eversley, PhD, DABMG

Co-Discipline Director, Molecular Genetics and Genomics, Labcorp

Joe Kearney, PhD

Jonathan L. Klein, MD

Medical Director, Integrated Oncology and Dianon Pathology

Kerry Deutsch, PhD

Bioinformatics Lead Scientist, Specialty Genomics

Melanie S. Trapani, PhD

Technical Director, Discipline Director (Identity/Paternity/ Relationship/Cell Line Authentication) and AABB Laboratory Director

Philip R. Wyatt, MD, PhD

Discipline Director, Biochemical Genetics, Labcorp

Ruth Heim, PhD, FACMG

Discipline Director, Molecular Genetics and Genomics, Labcorp